Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $23.16, but opened at $22.05. Daiichi Sankyo shares last traded at $22.87, with a volume of 47,494 shares.
Analyst Ratings Changes
Separately, Nomura Securities upgraded Daiichi Sankyo to a "strong-buy" rating in a research note on Friday, June 6th.
Check Out Our Latest Stock Analysis on Daiichi Sankyo
Daiichi Sankyo Stock Performance
The stock has a 50 day simple moving average of $24.79 and a 200 day simple moving average of $25.11. The company has a current ratio of 2.53, a quick ratio of 1.85 and a debt-to-equity ratio of 0.06. The stock has a market cap of $43.34 billion and a P/E ratio of 22.21.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.30 EPS for the quarter. Daiichi Sankyo had a return on equity of 17.92% and a net margin of 15.65%. The firm had revenue of $3.40 billion for the quarter. On average, equities analysts expect that Daiichi Sankyo Co., Ltd. - Sponsored ADR will post 0.73 earnings per share for the current year.
Daiichi Sankyo Company Profile
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Recommended Stories
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
